Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The EVICEL® Gastrointestinal Study

ClinicalTrials.gov ID: NCT01589822

Public ClinicalTrials.gov record NCT01589822. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 11:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques

Study identification

NCT ID
NCT01589822
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ethicon, Inc.
Industry
Enrollment
214 participants

Conditions and interventions

Interventions

  • EVICEL Fibrin Sealant Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2012
Primary completion
Dec 31, 2013
Completion
Aug 31, 2014
Last update posted
Feb 24, 2015

2012 – 2014

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Clinical Investigation Site #1 Irvine California 92868
Clinical Investigation Site #2 Jacksonville Florida 32099
Clinical Investigation Site #5 Augusta Georgia 30912
Clinical Investigation Site #4 New Orleans Louisiana 70121
Clinical Investigation Site #8 Portland Oregon 97239
Clinical Investigation Site #23 Greenville South Carolina 29605
Clinical Investigation Site #3 Houston Texas 77030
Clinical Investigation Site #6 Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01589822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2015 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01589822 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →